Understanding the Incredible Growth Trajectory of Oncotarget

Oncotarget is a highly reputable oncology journal online publisher founded by two eminent researchers. The chief editors are Mikhail Blagosklonny and Andrei V. Gudkov. The duo set up the peer-to-peer journal in 2010 with the intentions of speeding up the medical research process. In the past, scientists had to painstakingly wade their way through the mud to get published and reviewed by their academic peers. Those days, it was commonplace to find famous researchers, unknowingly, wasting valuable years and money researching on an aspect that had already been found elsewhere. Oncortaget sought to avoid such costly conundrums with their real-time online publishing journal.

Scholars jumped on the Oncotarget bandwagon in droves. This journal publishes on cancer research but has recently expanded to accommodate other medical fields’ journals. According to the expert reviews posted here, the journal’s receivership peaked in 2013 heading into 2014. The number of external citations per document had risen steadily in the last two years. The external citations per journal at Oncotarget has shot from below 5,000 to 20,000 since 2014.Effectively, and, as anticipated, Oncotarget succeeds in bringing together scholars from all parts of the world. There were increased collaborations among internationally based peers working on the same problem sets, according to the trusted journal rating website.

U.S-based authors and researchers have a record of well over a million medical journals published on Oncotarget in the last five years. Chinese scholars and scientists racked up a tally of almost half a million oncology journals at the site.Finding research data and statistics on Oncotarget is a straightforward, well-outlined process. The author has to be familiar with the indexing style accepted by Mikhail Blagosklonny and Andrei V. Gudkov at their resource portal. It is essential you, as the prospective medical author, get to read the open source agreement, in-depth, before publishing at Oncortaget. That helps to avoid any misunderstandings between you and the editors at this Medicus/MEDLINE/PublMed indexed award-winning scientific journal.